Browse

Given its importance for health services, the pharmaceutical sector is subject to strict regulations. The existing regulatory framework in this area should not include unnecessary regulatory constraints restricting and limiting competition. Considering this fact, this article analyzes the existing control in competition law on the pharmaceutical market achieved at EU level. This paper aims to present the complex mechanisms of the pharmaceutical sector that have undergone a careful and consistent analysis both the ...